medicationPrescription only (US)Approved by the FDA (Celebrex) as a selective COX-2 inhibitor NSAID for osteoarthritis, rheumatoid arthritis, and acute painCarries a boxed warning for cardiovascular thrombotic events and gastrointestinal bleeding shared with other NSAIDs
CelecoxibBenefits, Dosage & Interactions
Also known as: Celebrex
Celecoxib, marketed under the brand name Celebrex, is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve pain and inflammation. It belongs to a class of NSAIDs known as COX-2 selective inhibitors. It is typically taken with a meal. The reported plasma half-life is about 11 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 2 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
2 human randomized trials and regulatory approval on file.
Plasma half-life
~11 h
Typical timing
with meal
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Osteoarthritis trials used 200 mg/day; the large cardiovascular-safety trial (PRECISION) titrated celecoxib to 100–200 mg twice daily[1][2]
Reported for Celecoxib in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Celecoxib entry is written from. Each number matches an inline marker above.
- [1]Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxibHochberg MC, Martel-Pelletier J, Monfort J, Möller I, Castillo JR, Arden N · Annals of the Rheumatic Diseases · 2016 · Peer-reviewed · PMID 25589511
- [2]Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisNissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME · The New England Journal of Medicine · 2016 · Peer-reviewed · PMID 27959716
How to track Celecoxib doses
Tracking Celecoxib well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Celecoxib with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is with_meal. Take it with food, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Celecoxib through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 11 h, effects and timing shifts show up over days rather than instantly. Review Celecoxib alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day and whether it was taken with food
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Celecoxib dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Celecoxib?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Celecoxib, marketed under the brand name Celebrex, is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve pain and inflammation. It belongs to a class of NSAIDs known as COX-2 selective inhibitors. Unlike traditional NSAIDs which inhibit both COX-1 and COX-2 enzymes, celecoxib predominantly targets the COX-2 enzyme. This selectivity is intended to reduce certain gastrointestinal side effects often associated with non-selective NSAIDs, such as stomach ulcers and bleeding. Celecoxib is prescribed for various conditions, including osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain, and primary dysmenorrhea. It is taken orally, typically once or twice daily, and is available by prescription only. (Mayo Clinic, FDA label)
What does the research say about Celecoxib?
Tap a section to expand.
Celecoxib exerts its therapeutic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme. Cyclooxygenase enzymes are responsible for the synthesis of prostaglandins, which are lipid compounds that play a crucial role in mediating inflammation, pain, and fever. There are two main isoforms of cyclooxygenase: COX-1 and COX-2. COX-1 is constitutively expressed in most tissues and is involved in maintaining normal physiological functions, such as protecting the stomach lining, supporting kidney function, and promoting platelet aggregation. In contrast, COX-2 is largely inducible, meaning its expression increases significantly at sites of inflammation, injury, or infection, leading to increased production of pro-inflammatory prostaglandins. By selectively inhibiting COX-2, celecoxib reduces the production of these inflammatory prostaglandins, thereby alleviating pain, inflammation, and fever. The selectivity for COX-2 over COX-1 is hypothesized to spare some of the protective functions mediated by COX-1, potentially leading to a lower incidence of gastrointestinal side effects compared to non-selective NSAIDs. (FDA label, DrugBank)
Source for this section: Sources for How does Celecoxib work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefits of celecoxib stem from its ability to reduce pain and inflammation. It is indicated for the symptomatic treatment of several conditions:
* **Osteoarthritis:** Celecoxib effectively reduces joint pain and improves physical function in individuals with osteoarthritis. (Mayo Clinic)
* **Rheumatoid Arthritis:** It helps alleviate pain, reduce inflammation, and decrease morning stiffness in patients with rheumatoid arthritis. (Mayo Clinic)
* **Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older:** Celecoxib is approved to manage the signs and symptoms of JRA, providing relief from joint pain and inflammation in pediatric patients. (FDA label)
* **Ankylosing Spondylitis:** This medication can significantly reduce pain and stiffness associated with ankylosing spondylitis. (Mayo Clinic)
* **Acute Pain:** Celecoxib is effective in managing various types of acute pain, including postoperative pain and musculoskeletal pain. (FDA label)
* **Primary Dysmenorrhea:** It can alleviate menstrual pain and cramps. (FDA label)
By targeting the COX-2 enzyme specifically, celecoxib aims to offer pain and inflammation relief with a potentially reduced risk of gastrointestinal adverse effects compared to non-selective NSAIDs. (FDA label)
The efficacy and safety of celecoxib have been established through numerous clinical trials. For example, studies have demonstrated its effectiveness in reducing pain scores and improving functional outcomes in patients with osteoarthritis and rheumatoid arthritis. A systematic review and meta-analysis published in the journal *Cochrane Database of Systematic Reviews* has assessed the efficacy and tolerability of celecoxib for various painful conditions, often concluding that it provides effective pain relief. The FDA's approval of celecoxib is based on comprehensive data from clinical trials showing its ability to manage pain and inflammation in its approved indications. These trials evaluated celecoxib against placebo and other NSAIDs, consistently showing its therapeutic benefits. (Cochrane, FDA label)
Like all medications, celecoxib can cause side effects, though not everyone experiences them. Common side effects often include:
* Abdominal pain
* Diarrhea
* Indigestion (dyspepsia)
* Flatulence
* Nausea
* Headache
* Dizziness
* Swelling of the extremities (peripheral edema)
More serious, but less common, side effects can include:
* Serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. (FDA label)
* Gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. (FDA label)
* Kidney problems, including acute renal failure. (NIH ODS)
* Liver problems, including liver failure. (NIH ODS)
* Serious skin reactions such as exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis. (FDA label)
* Allergic reactions, including anaphylaxis. (NIH ODS)
Patients should report any unusual or severe symptoms to their healthcare provider. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Celecoxib carries several important warnings. It should be used with caution, and its use should be carefully weighed against potential risks.
* **Cardiovascular Risk:** Celecoxib, like other NSAIDs, may cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may increase with duration of use and in patients with pre-existing cardiovascular disease or risk factors. (FDA label)
* **Gastrointestinal Risk:** NSAIDs, including celecoxib, increase the risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. Elderly patients and patients with a history of peptic ulcer disease and/or GI bleeding are at greater risk. (FDA label)
* **Hypertension:** NSAIDs, including celecoxib, can lead to new onset of hypertension or worsening of pre-existing hypertension, either of which may contribute to the increased incidence of cardiovascular events. (FDA label)
* **Heart Failure and Edema:** Fluid retention and edema have been observed in some patients taking NSAIDs. Celecoxib should be used with caution in patients with fluid retention or heart failure. (FDA label)
* **Renal Effects:** Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury. Caution is advised in patients with impaired renal function, heart failure, or liver dysfunction, and in the elderly. (FDA label)
* **Anaphylactoid Reactions:** As with other NSAIDs, anaphylactoid reactions may occur in patients without known prior exposure to celecoxib. (FDA label)
* **Serious Skin Reactions:** Celecoxib can cause serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN). (FDA label)
Please discuss all your medical conditions and medications with your doctor before starting celecoxib. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Celecoxib is contraindicated in certain situations due to potential risks. It should not be used by individuals with:
* **Known hypersensitivity** to celecoxib or any component of the drug. (FDA label)
* **Known aspirin allergy or allergic reactions to other NSAIDs**, as cross-reactivity can occur. (FDA label)
* **History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.** Severe, rarely fatal, anaphylactoid reactions to NSAIDs have been reported in such patients. (FDA label)
* **Known hypersensitivity to sulfonamides.** Celecoxib contains a sulfonamide group, and patients with sulfonamide allergies may be at risk of allergic reactions. (FDA label)
* **In the setting of coronary artery bypass graft (CABG) surgery.** NSAIDs are contraindicated for the treatment of peri-operative pain in the setting of CABG surgery. (FDA label)
* **Advanced renal disease** unless close monitoring is possible. (EMA SmPC)
* **Severe uncontrolled heart failure.** (EMA SmPC)
* **Active gastrointestinal ulcers or bleeding.** (EMA SmPC)
* **Inflammatory bowel disease** (Crohn's disease or ulcerative colitis). (EMA SmPC)
It is crucial to inform your healthcare provider about all your medical history and allergies before taking celecoxib. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Mixing celecoxib with certain other medications can increase the risk of adverse effects or alter the effectiveness of either drug. Key interactions to be aware of include:
* **Other NSAIDs (e.g., ibuprofen, naproxen) or aspirin (at analgesic doses):** Concomitant use increases the risk of gastrointestinal bleeding and other side effects without providing additional therapeutic benefit. (FDA label)
* **Blood thinners (anticoagulants) such as warfarin:** Celecoxib can enhance the anticoagulant effect of warfarin, leading to an increased risk of bleeding. Close monitoring of INR is recommended. (FDA label)
* **Corticosteroids:** Concurrent use with celecoxib may further increase the risk of gastrointestinal ulcers or bleeding. (Mayo Clinic)
* **Diuretics (e.g., furosemide, hydrochlorothiazide):** Celecoxib can reduce the natriuretic effect of diuretics, potentially leading to fluid retention and worsened hypertension. (FDA label)
* **ACE inhibitors and Angiotensin II Receptor Blockers (ARBs):** NSAIDs can diminish the antihypertensive effect of these medications and increase the risk of renal impairment, especially in elderly or dehydrated patients. (FDA label)
* **Lithium:** Celecoxib can increase plasma lithium levels, potentially leading to lithium toxicity. (FDA label)
* **Cyclosporine:** Concomitant use may increase the nephrotoxicity of cyclosporine. (FDA label)
* **Methotrexate:** Celecoxib may increase the plasma concentrations of methotrexate, potentially increasing its toxicity. (FDA label)
* **Fluconazole:** This antifungal medication can significantly increase celecoxib plasma concentrations. The celecoxib dosage may need to be reduced when used concurrently. (FDA label)
* **Pemetrexed:** Co-administration may increase myelosuppression, renal, and gastrointestinal toxicity of pemetrexed. (FDA label)
Always provide your clinician with a complete list of all medications, supplements, and herbal products you are currently taking. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Celecoxib is typically taken orally with food to help reduce the risk of gastrointestinal upset. The dose and frequency of administration will be determined by a licensed clinician based on the specific condition being treated, the patient's individual response, and other medical factors. It is generally taken once or twice daily. For acute pain or primary dysmenorrhea, it may be prescribed on an as-needed basis or for a short course. For chronic conditions like arthritis, it is usually taken regularly as prescribed. Adherence to the prescribed dosing schedule and food instructions is important for optimal efficacy and to minimize side effects. (FDA label)
Source for this section: Sources for When should you take Celecoxib?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Celecoxib?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
Frequently asked questions about Celecoxib
Celecoxib is a medication. It is also known as Celebrex. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Celecoxib is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Celecoxib, it is typically taken with a meal, it is usually taken with food, and its approximate half-life is 11 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
Celecoxib carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Celecoxib comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Celecoxib is usually taken with a meal, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 11 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Celecoxib with no sign-up.
There is no single answer for Celecoxib plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Celecoxib with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 11 hours, once-daily dosing is the usual pattern for Celecoxib. It is typically taken with a meal. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
With a plasma half-life near 11 hours, a single missed dose of Celecoxib usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Celecoxib the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Celecoxib?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis(opens PubMed in a new tab)N Engl J Med · 2016 · PMID 27959716 · https://pubmed.ncbi.nlm.nih.gov/27959716/
- 2.Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.(opens PubMed in a new tab)Clinical pharmacokinetics · 2000 · PMID 10749518 · https://pubmed.ncbi.nlm.nih.gov/10749518/
- 3.Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial(opens PubMed in a new tab)JAMA · 2021 · PMID 33821899 · https://pubmed.ncbi.nlm.nih.gov/33821899/
- 4.Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib(opens PubMed in a new tab)Ann Rheum Dis · 2016 · PMID 25589511 · https://pubmed.ncbi.nlm.nih.gov/25589511/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 2662(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/2662
Verify at
Publisher search links for Celecoxib. These are places to check the information — they are not citations, so they are not numbered.
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Celecoxib?
Plain-text summary, safe to quote verbatim:
Celecoxib, marketed under the brand name Celebrex, is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve pain and inflammation. It belongs to a class of NSAIDs known as COX-2 selective inhibitors. It is typically taken with a meal. The reported plasma half-life is about 11 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/celecoxib
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Celecoxib — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/celecoxib
What compounds are similar to Celecoxib?
Others in the medication category or studied for the same goals.